Vytora Health Review
Best for: Patients seeking month-to-month or 3-month-bundle compounded semaglutide or tirzepatide with the option of brand-name Mounjaro/Zepbound on a single LegitScript-approved + HIPAA-compliant platform with named pharmacy partners and transparent operating-PC disclosure. Particularly suited for patients in KS, LA, MS, NM, WV where Vytora's audio-visit option satisfies state telehealth compliance.
Vytora Health (vytorahealth.com) is a 50-state + DC compounded-GLP-1 telehealth platform operated by Wasef Health, PC (Pinellas Park, Florida) with pharmacy fulfillment partners Vials Pharmacy (Texas) and Greenwich Biosciences. The platform offers month-to-month and 3-month-bundle compounded semaglutide ($180/$150) and compounded tirzepatide ($249/$200) plus brand-name Mounjaro and Zepbound at retail-comparable pricing. NAD+ and Sermorelin peptides also offered. Live-verified 2026-05-15: LegitScript-approved and HIPAA-compliant; video- or audio-visit required for compliance in KS, LA, MS, NM, WV. WLR clinical-network disclosure (2026-05-15): clinical prescribing services are contracted to Wasef Health, PC (Pinellas Park, FL; Director Michael Wasef, MD), a multi-platform telehealth physician group that also prescribes for Cora Health, Refills Health, and sermorelin.com. Pharmacy partners and corporate operator are distinct from those other brands.
High confidence · Last verified 2026-05-15 via manual · How we verify provider data
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Vytora Health is one of the most affordable GLP-1 options on the market.
Score Breakdown
Drugs Offered
Vytora Health prescribes the following GLP-1 medications. Tap a drug to read our clinical guide with FDA label info, dosing schedules, side effects, and trial data.
Pricing
| Dose | Form | Price/mo |
|---|---|---|
| All doses | compounded | $180 |
| 3-mo bundle ($450 billed) | compounded | $150 |
| All doses | compounded | $249 |
| 3-mo bundle ($599 billed) | compounded | $200 |
| Brand 5/7.5/10/12.5/15 mg | brand | $1399 |
| Brand 2.5/5/7.5/10/12.5/15 mg | brand | $1399 |
✓ Pros
- •All 50 states + DC coverage with explicit per-state-modality compliance (video vs audio) disclosure
- •Both compounded AND brand-name options on a single platform — uncommon (most compounded-focused providers do not offer brand)
- •LegitScript Approved + HIPAA Compliant — both disclosed primary-source-verifiable
- •Pharmacy partners named publicly: Vials Pharmacy (TX) + Greenwich Biosciences — uncommon transparency
- •Owner / operating PC disclosed: Wasef Health, PC (Pinellas Park, FL)
- •Month-to-month pricing competitive ($180 sema / $249 tirz) and 3-month bundle (17% discount) for cost-sensitive patients
- •Brand-name Mounjaro and Zepbound available for patients who can self-pay $1,399/mo for FDA-approved options
- •Adjunct peptide offerings (NAD+, Sermorelin) for patients pursuing broader optimization regimens
✗ Cons
- •Brand-name Mounjaro/Zepbound pricing ($1,399/mo) is near-retail; insured patients should pursue PA through traditional pharmacy + LillyDirect Self Pay Journey Program ($449-$699/mo) for better economics
- •Compounded tirzepatide tier ($249/mo) is above the lowest market floor ($149-199/mo) — Vytora pricing is mid-market for compounded
- •Specific dose-tier pricing not publicly broken out — pricing shown as 'all doses included' which is favorable but means high-dose patients pay the same as low-dose patients
- •Initial consultation cost not disclosed on public-facing pricing page (some providers free, some $99)
- •Limited primary-source-verifiable state licensure detail per individual prescriber (most multi-state telehealth platforms have this gap)
Ready to start with Vytora Health?
Starting at $150/month. See current pricing and start your free consultation.
Sources & methodology
Our Vytora Health review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of May 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Alternatives to Vytora Health
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Ready to start with Vytora Health?
Starting at $150/month. See current pricing and start your free consultation.